Welcure Drugs & Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis
WELCURE
Pharmaceuticals
Share Price BSE
₹0.32
▼
-0.01 (-3.03%)
As of April 17, 2026, the Welcure Drugs & Pharmaceuticals share price (BSE: WELCURE) is ₹0.32, down 3.03% from the previous close, with shares trading between ₹0.32 and ₹0.32, and a 52-week range of ₹0.24–₹15.89.
Browse WELCURE complete financial to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Welcure Drugs & Pharmaceuticals Market Cap
₹43.24 Cr.
WELCURE P/E Ratio (TTM)
1.17
Welcure Drugs & Pharmaceuticals P/B Ratio
0.31
EPS (TTM)
₹0.36
Dividend Yield
-
Debt to Equity
1.19
WELCURE 52 Week High
₹15.89
Welcure Drugs & Pharmaceuticals 52 Week Low
₹0.24
Operating Margin
8.00%
Profit Margin
8.97%
WELCURE Revenue (TTM)
₹390.00
EBITDA
₹46.00
Net Income
₹35.00
Total Assets
₹267.00
Total Equity
₹103.00
Welcure Drugs & Pharmaceuticals Share Price History - Stock Screener Chart
Screen WELCURE historical share price movements with interactive charts. Analyze price trends and patterns.
Welcure Drugs & Pharmaceuticals Company Profile - Fundamental Screener
Screen Welcure Drugs & Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for WELCURE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE331C01025
Welcure Drugs & Pharmaceuticals Balance Sheet Screener
Screen WELCURE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 267 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 182 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 123 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 103 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Capital | 112 | 13 | 13 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| Reserves & Surplus | -10 | -12 | -12 | -12 | -12 | -12 | -12 | -12 | -12 | -12 |
Welcure Drugs & Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Welcure Drugs & Pharmaceuticals income statement and profit fundamentals.
Analyze WELCURE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Welcure Drugs & Pharmaceuticals share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 390 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 344 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 46 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | 8.00% | 4.00% | 0.00% | 0.00% | 22.00% | 41.00% | -12.00% | 3.00% | -41.00% | 31.00% | 32.00% | 7.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 46 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 11 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 35 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 3.30 | 0.36 | -0.13 | 0.08 | 0.02 | 0.05 | -0.01 | 0.00 | -0.02 | 0.02 | 0.07 | 0.00 |
Welcure Drugs & Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen WELCURE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -222 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 222 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Welcure Drugs & Pharmaceuticals Shareholding Pattern Screener
See Welcure Drugs & Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check Welcure Drugs & Pharmaceuticals promoter holding and ownership changes for WELCURE on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 98.99% | 98.74% | 91.83% | 94.41% | 93.69% | 93.14% | 93.55% | 98.79% |
| Other Holding | 1.01% | 1.26% | 8.17% | 5.59% | 6.31% | 6.86% | 6.45% | 1.21% |
| Shareholder Count | 32,366 | 37,298 | 76,954 | 87,288 | 31,530 | 31,045 | 30,218 | 30,605 |
Welcure Drugs & Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check Welcure Drugs & Pharmaceuticals dividend history with payout and yield data.
View Welcure Drugs & Pharmaceuticals dividend details including ex-dates and amounts for WELCURE stock.
Welcure Drugs & Pharmaceuticals Stock Index Membership
See which indices include Welcure Drugs & Pharmaceuticals stock.
Check WELCURE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Welcure Drugs & Pharmaceuticals Market Events Screener - Corporate Actions
Get Welcure Drugs & Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check Welcure Drugs & Pharmaceuticals stock events that may affect WELCURE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 4.48% | ||
| Annual General Meeting | NA | -31.25% | ||
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 9.09% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 10.91% |
| 2025-10-16 | 2025-10-16 | Bonus | 1:10 | 23.33% |
| 2025-10-16 | 2025-08-22 | Split | 1:10 | 0.00% |
| 2025-08-05 | 2025-08-05 | Quarterly Result Announcement | NA | 2.33% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 6.93% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -10.64% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 4.29% |
Welcure Drugs & Pharmaceuticals Competitors Screener - Peer Comparison
Screen WELCURE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 396,418 | 36.25 | 54,729 | 9.71% | 10,980 | 33.68 |
| Divis Laboratories | 161,139 | 65.53 | 9,712 | 18.67% | 2,191 | 50.76 |
| Torrent Pharmaceuticals | 141,504 | 61.93 | 11,539 | 6.99% | 1,911 | 49.76 |
| Lupin | 105,810 | 22.84 | 22,910 | 13.74% | 3,306 | 53.72 |
| Dr Reddys Laboratories | 103,154 | 18.62 | 33,741 | 16.73% | 5,725 | 46.43 |
| Cipla | 97,830 | 21.91 | 28,410 | 7.12% | 5,291 | 36.48 |
| Zydus Life Science | 92,815 | 18.33 | 23,511 | 18.55% | 4,615 | 59.14 |
| Mankind Pharma | 85,756 | 47.59 | 12,744 | 20.90% | 2,007 | 51.41 |
| Aurobindo Pharma | 77,816 | 22.50 | 32,346 | 9.43% | 3,484 | 62.63 |
| Alkem Laboratories | 64,141 | 26.85 | 13,458 | 3.70% | 2,216 | 49.73 |
Welcure Drugs & Pharmaceuticals Company Announcements - News Screener
Screen WELCURE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-26 | Closure of Trading Window | - |
| 2026-02-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-12 | Unaudited Financial Results For The 3Rd Quarter Ended On 31St December 2025. | - |
| 2026-02-12 | Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Thursday 12Th February 2026 | - |
| 2026-02-07 | Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors To Be Held On Thursday February 12 2026. | - |
| 2026-01-05 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-24 | Closure of Trading Window | - |
| 2025-12-06 | Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs And Pharmaceuticals Limited Held Today I.E. Saturday December 06 2025 | - |
| 2025-12-05 | Postponement Of The Meeting Of The Rights Issue Committee Of Welcure Drugs And Pharmaceuticals Limited Which Was To Be Held Today I.E. Monday December 05 2025 | - |
| 2025-12-01 | Board Meeting Intimation for Intimation Of Rights Issue Committee Meeting To Be Held On 05Th December 2025 For Deciding Issue Price And Other Terms Of The Rights Issue | - |
| 2025-12-01 | Announcement under Regulation 30 (LODR)-Resignation of Director | - |
| 2025-12-01 | Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs And Pharmaceuticals Limited Held Today I.E. Monday December 01 2025 | - |
| 2025-11-27 | Board Meeting Intimation for Postponement Of Board Meeting Which Was To Be Held On Thursday 27Th November 2025 | - |
| 2025-11-24 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday November 27 2025 | - |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-13 | Result- Unaudited Financial Statement For The Quarter And Half Year Ended 30Th September 2025 | - |
| 2025-11-13 | Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Thursday 13Th November 2025. | - |
| 2025-11-08 | Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results For The Quarter And Half Year Ended September 30 2025 Along With Limited Review Report (Financial Results). | - |
| 2025-10-17 | Board Meeting Outcome for Outcome Of The Board Meeting-Allotment Of Bonus Shares | - |